Viridian Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
CERE
Cerevel Therapeutics Holdings, Inc. |
$0.00 | $8.19 B | -16.47 | 355 |
ETNB
89bio, Inc. |
$7.53 | $1.12 B | -2.21 | 93 |
GPCR
Structure Therapeutics Inc. |
$26.44 | $502.40 M | -11.24 | 163 |
KURA
Kura Oncology, Inc. |
$5.64 | $493.91 M | -2.73 | 192 |
CYTK
Cytokinetics, Incorporated |
$33.11 | $3.98 B | -6.35 | 498 |
ICVX
Icosavax, Inc. |
$0.00 | $769.04 M | -6.96 | 60 |
MRUS
Merus N.V. |
$39.13 | $2.73 B | -11.8 | 260 |
RVMD
Revolution Medicines, Inc. |
$37.55 | $7.03 B | -10.54 | 534 |
PCVX
Vaxcyte, Inc. |
$28.90 | $3.78 B | -7.71 | 414 |
SNDX
Syndax Pharmaceuticals, Inc. |
$9.98 | $864.31 M | -2.61 | 270 |
BPMC
Blueprint Medicines Corporation |
$98.94 | $6.42 B | -92.87 | 682 |
CRNX
Crinetics Pharmaceuticals, Inc. |
$31.17 | $2.94 B | -8.5 | 437 |
INZY
Inozyme Pharma, Inc. |
$1.35 | $88.77 M | -0.85 | 67 |
NUVL
Nuvalent, Inc. |
$66.58 | $4.79 B | -16.99 | 142 |
REPL
Replimune Group, Inc. |
$7.03 | $546.81 M | -2.31 | 331 |
PTGX
Protagonist Therapeutics, Inc. |
$42.79 | $2.61 B | 10.05 | 126 |
PLRX
Pliant Therapeutics, Inc. |
$1.40 | $88.09 M | -0.41 | 171 |
TERN
Terns Pharmaceuticals, Inc. |
$3.00 | $265.82 M | -2.72 | 59 |
ACLX
Arcellx, Inc. |
$52.30 | $2.84 B | -25.78 | 163 |
DICE
DICE Therapeutics, Inc. |
$0.00 | $2.27 B | -21.91 | 71 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
